Javelin Biotech
1 known investors
Javelin Biotech develops an organ-on-a-chip platform using human microphysiological systems (MPS) to generate clinically-relevant preclinical data for drug discovery. It serves pharmaceutical and therapeutic developers seeking to predict human response and identify drug candidates earlier across a range of drug modalities.
Investors · 1
In the news
Frequently asked questions
- What does Javelin Biotech do?
- Javelin Biotech develops an organ-on-a-chip platform using human microphysiological systems (MPS) to generate clinically-relevant preclinical data for drug discovery. It serves pharmaceutical and therapeutic developers seeking to predict human response and identify drug candidates earlier across a range of drug modalities.
- Who are Javelin Biotech's investors?
- Javelin Biotech's investors include Social Starts.